• 

  December 16, 2025

  Understanding HER2 positive Breast Cancer and its Treatment

  Charles H. Weaver, MD

• 

  July 26, 2025

  Precision Cancer Medicines and Breast Cancer

  Charles H. Weaver, MD

• 

  January 22, 2021

  Side Effects of Cancer Treatment: Heart/Cardiac Toxicity Overview

  Charles H. Weaver, MD

• 

  January 15, 2021

  HER2, Herceptin and Precision Cancer Medicines Targeting Gastric Cancer

  Charles H. Weaver, MD

• 

  August 28, 2020

  Treatment of Stage IV Bladder Cancer

  Charles H. Weaver, MD

• 

  February 25, 2020

  Esophageal Cancer Survival Improved Using Precision Cancer Medicines

  Charles H. Weaver, MD

• 

  December 17, 2019

  Kadcyla (T-DM1) Significantly Improves Treatment of HER 2 + Breast Cancers

  Charles H. Weaver, MD

• 

  July 29, 2019

  Treatment for Stage IV Gastric Cancer

  Charles H. Weaver, MD

• 

  June 12, 2019

  Herceptin Treatment of HER2-positive Advanced-Metastatic Breast Cancer

  Charles H. Weaver, MD

• 

  May 1, 2019

  Herceptin® Improves Cancer-Free Survival in HER2 + positive Early Breast Cancer

  Charles H. Weaver, MD

• 

  September 27, 2018

  Treatment of Recurrent Esophageal Cancer

  Charles H. Weaver, MD

• 

  April 16, 2018

  Targeting HER2 in Uterine Cancer

  Charles H. Weaver, MD